COVID-19 Vaccines - Belize

Belize

Highlights

The COVID-19 Vaccines market in Belize is expected to witness significant growth in the coming years.
By 2024, the projected revenue is estimated to reach US$2.22m.
Furthermore, it is anticipated that the market will experience a robust compound annual growth rate (CAGR) of -18.26% between 2024 and 2029.
This growth trajectory is expected to result in a market volume of US$810.10k by 2029.
When comparing in Belize to other countries globally, it is important to note that United States is expected to generate the highest revenue in the COVID-19 Vaccines market.
In 2024, the projected revenue for the United States is estimated to be a staggering US$4.39bn.
This highlights the significant market potential and demand for COVID-19 vaccines United States.
Belize is making strides in its COVID-19 vaccine distribution, prioritizing remote communities and vulnerable populations.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

Despite the small size of Belize, the country has a unique market for COVID-19 vaccines. As of now, the country has a low vaccination rate, with only a small percentage of the population fully vaccinated.

Customer preferences: Belize's market for COVID-19 vaccines is unique, as the country's population is small and dispersed. This means that the market is not as competitive as in larger countries, and there are not as many options for vaccines. Additionally, the population is diverse, with many different ethnic groups and languages spoken, which can make it challenging to communicate with everyone about the importance of getting vaccinated.

Trends in the market: One trend in the Belizean market for COVID-19 vaccines is the government's efforts to increase vaccination rates. The government has been working to provide more information about the vaccines and their benefits, as well as making the vaccines more accessible to the public. Another trend is the use of mobile vaccination clinics to reach more remote areas of the country.

Local special circumstances: One of the challenges in the Belizean market for COVID-19 vaccines is the country's geography. Belize is a small country with a dispersed population, which can make it challenging to distribute vaccines to everyone who needs them. Additionally, there are many different ethnic groups and languages spoken in Belize, which can make it challenging to communicate with everyone about the importance of getting vaccinated.

Underlying macroeconomic factors: The Belizean economy has been heavily impacted by the COVID-19 pandemic, which has led to a decrease in economic activity and a rise in unemployment. This has made it challenging for many people to access healthcare, including vaccines. Additionally, the country's healthcare system has limited resources, which can make it challenging to distribute vaccines to everyone who needs them. Despite these challenges, the government is working to increase vaccination rates and protect the population from the COVID-19 pandemic.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.